Satellos Bioscience Inc (MSLE) Price Prediction & ForecastMSLEForecastSatellos Bioscience Inc

Alphio's MSLE stock price prediction model matches the current Satellos Bioscience Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $8.67 (+0.10%). The 1-week path is $8.53 (-1.51%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Currently, Satellos Bioscience Inc (MSLE) is trading at $8.66, down 26.70% year-to-date, which indicates a significant decline. Despite receiving FDA Fast Track Designation for its drug SAT-3247, the company has reported consistent net losses, with the latest quarterly net income at -11,718,000 USD. Analysts have set a price target range from $18 to $23, suggesting a potential upside of 107% to 165%. However, the RSI is at 22.546, indicating the stock is oversold, which may present a buying opportunity, but the persistent losses and high risk associated with clinical trials remain a concern.

Satellos Bioscience Inc (MSLE) last closed at $8.66, losing -9.89%. These facts feed the 1-day and 1-week MSLE price prediction above.